SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
29-Apr-24 4:17 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Apr-24 | Option Exercise | 8,032 | -- | -- | 10% 79.62K to 87.65K | |
03-Jul-23 4:57 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 30-Jun-23 | Grant | 21,219 | -- | -- | 111% 19.2K to 40.41K | |
22-May-23 4:02 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 21-May-23 | Option Exercise | 9,302 | -- | -- | 13% 70.31K to 79.62K | |
16-Jun-22 4:10 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 14-Jun-22 | Grant | 15,822 | -- | -- | 469% 3.37K to 19.2K | |
02-May-22 4:12 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 30-Apr-22 | Option Exercise | 4,024 | -- | -- | 6% 66.29K to 70.31K | |
02-Dec-21 4:07 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 30-Nov-21 | Market Sale | 12 | $3.57 | $42.86 | (< 1%) 3.39K to 3.37K | (< 1%) |
25-Aug-21 4:16 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 24-Aug-21 | Market Purchase | 1,000 | $5.00 | $5,000.00 | 42% 2.39K to 3.39K | < 1% |
17-Jun-21 4:08 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 15-Jun-21 | Grant | 2,374 | -- | -- | 19783% 12 to 2.39K | |
27-Apr-21 4:46 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 24-Apr-21 | Option Exercise | 10,638 | -- | -- | 19% 55.65K to 66.29K | |
27-Apr-20 4:44 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 26-Apr-20 | Option Exercise | 3,466 | -- | -- | 7% 52.19K to 55.65K | |
02-Aug-19 4:12 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 02-Aug-19 | Market Purchase | 24,000 | $1.17 | $28,200.00 | 85% 28.19K to 52.19K | 197% |
27-Apr-18 5:36 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 27-Apr-18 | Grant | 2,564 | -- | -- | 10% 25.62K to 28.19K | |
18-Sep-17 6:36 AM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 15-Sep-17 | Market Purchase | 1,000 | $12.50 | $12,500.00 | 4% 24.62K to 25.62K | (72%) |
01-May-17 4:48 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 28-Apr-17 | Grant | 1,281 | -- | -- | 5% 23.34K to 24.62K | |
02-May-16 5:47 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 29-Apr-16 | Grant | 1,432 | -- | -- | 7% 21.91K to 23.34K | |
24-Apr-15 5:24 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 24-Apr-15 | Grant | 18,691 | -- | -- | 14% 134.69K to 153.38K | |
20-Nov-14 4:24 PM View: | Cyclacel Pharmaceuticals, I... (CYCC) | 20-Nov-14 | Market Purchase | 3,100 | $3.00 | $9,299.69 | 100% 0 to 3.1K | (99%) |
29-Apr-14 4:17 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 25-Apr-14 | Grant | 12,820 | -- | -- | 11% 121.86K to 134.69K | |
21-Mar-14 1:34 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 19-Mar-14 | Disposition (change in control) | 20,000 | $14.00 | $280,000.00 | (100%) 20.0K to 0 | < 1% |
13-May-13 4:57 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 10-May-13 | Grant | 10,101 | -- | -- | 9% 111.76K to 121.86K | |
27-Apr-12 4:33 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 27-Apr-12 | Grant | 11,764 | -- | -- | 12% 100.0K to 111.76K | |
27-Dec-11 4:12 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 22-Dec-11 | Option Exercise | 34,000 | $1.13 | $38,420.00 | 52% 66.0K to 100.0K | (56%) |
11-May-11 4:51 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 10-May-11 | Market Purchase | 9,000 | $7.04 | $63,330.30 | 82% 11.0K to 20.0K | 12% |
26-Oct-09 4:15 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 22-Oct-09 | Market Purchase | 19,000 | $1.56 | $29,672.00 | 40% 47.0K to 66.0K | (67%) |
05-Feb-09 4:29 PM View: | Atherogenics Inc. (AGIX) | 04-Feb-09 | Sale | 6,000 | $0.04 | $210.00 | (23%) 26.0K to 20.0K | (43%) |
05-Feb-09 4:29 PM View: | Atherogenics Inc. (AGIX) | 04-Feb-09 | Sale | 20,000 | $0.04 | $720.00 | (100%) 20.0K to 0 | (39%) |
22-Apr-08 4:34 PM View: | Lexicon Pharmaceuticals, Inc. (LXRX) | 18-Apr-08 | Market Purchase | 40,000 | $1.96 | $78,569.80 | 571% 7.0K to 47.0K | (75%) |
19-Mar-08 7:44 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 17-Mar-08 | Market Purchase | 1,000 | $5.37 | $5,370.00 | 100% 0 to 1.0K | 38% |
19-Mar-08 7:44 PM View: | Cadence Pharmaceuticals Inc. (CADX) | 17-Mar-08 | Market Purchase | 10,000 | $5.24 | $52,360.40 | 1000% 1.0K to 11.0K | 41% |
01-Feb-08 11:00 AM View: | Atherogenics Inc. (AGIX) | 25-Jan-08 | Market Purchase | 5,000 | $0.39 | $1,950.00 | 500% 1.0K to 6.0K | 110% |
01-Feb-08 11:00 AM View: | Atherogenics Inc. (AGIX) | 25-Jan-08 | Market Purchase | 20,000 | $0.39 | $7,800.00 | 333% 6.0K to 26.0K | 110% |